Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma
Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma
Recruiting · NCT06567314 · Registry updated 2026-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma | skin squamous cell carcinoma | Recruiting | Phase 2 | 2026-06-11 | NCT06567314 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| M.D. Anderson Cancer Center | 1145 |
| Summit Therapeutics | 31 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MD Anderson Cancer Center | Houston | United States | 589 |